2013 parkinson's disease glutathione 4 authors journal G6PD deficiency triggers dopamine loss and the initiation of pathogenesis: Cell Reports Parkinson's disease-specific α-Synuclein variants potentially
Parkinson's disease specific Synuclein variants potentially drive Lewy body formation by engaging in promiscuous and non functional interactions Communications Biology Frontiers Microbiome based therapies for Parkinson's disease Gut microbiota and Parkinson's disease: exploring pathogenesis and potential therapeutic strategies from a gut brain axis perspective ScienceDirect Frontiers Neuroinflammation in Parkinson's disease: focus on the relationship between miRNAs and microglia Potential use of glutathione as a treatment for Parkinson's disease PMC Independent serum metabolomics approaches identify disrupted glutamic acid and serine metabolism in Parkinson's disease patients npj Parkinson's Disease
Pay in 4 interest-free payments of $5.47 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4





